{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:00:03Z","timestamp":1791806403471,"version":"4.3.4"},"reference-count":51,"publisher":"Wiley","issue":"15","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","award":["3811\u2010B96\u201301XAB (961607)"],"award-info":[{"award-number":["3811\u2010B96\u201301XAB (961607)"]}],"id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[1999,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Interleukin\u201018 (IL\u201018), also called interferon\u2010\u03b3 (IFN\u2010\u03b3)\u2010inducing factor, has recently been characterized as a potent IFN\u2010\u03b3\u2010inducing cytokine. We now report that IL\u201018 is a novel antiangiogenic and antitumor cytokine.\n                    <jats:italic>In vitro<\/jats:italic>\n                    , IL\u201018 specifically inhibits fibroblast growth factor\u20102\u2010stimulated proliferation of capillary endothelial cells.\n                    <jats:italic>In vivo<\/jats:italic>\n                    , IL\u201018 is sufficiently potent to suppress the fibroblast growth factor\u2010induced corneal neovascularization by systemic administration in mice. This cytokine also inhibits embryonic angiogenesis in the chick chorioallantoic membrane assay. Systemic and intralesional administrations of IL\u201018 produce a significant suppression of the growth of murine T241 fibrosarcoma in syngeneic C57Bl6\/J and immunodeficient SCID mice. The antitumor effect appears to be potent because an average of &gt;75% inhibition of primary tumor growth was observed at a dose of 50 \u00b5g\/kg\/day. In cell culture, murine T241 fibrosarcoma cells are insensitive to recombinant IL\u201018 at concentrations that significantly inhibit endothelial cell proliferation. Immunohistochemical studies of tumor tissues reveal hypovascularization of the IL\u201018\u2010treated tumors. These results suggest that IL\u201018 may participate in the regulation of a switch of tumor angiogenesis.\u2014Cao, R., Farnebo, J., Kurimoto, M., Cao, Y. Interleukin\u201018 acts as an angiogenesis and tumor suppressor.\n                    <jats:italic>FASEB J.<\/jats:italic>\n                    13, 2195\u20132202 (1999)\n                  <\/jats:p>","DOI":"10.1096\/fasebj.13.15.2195","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T04:15:54Z","timestamp":1516853754000},"page":"2195-2202","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":156,"title":["Interleukin\u201018 acts as an angiogenesis and tumor suppressor"],"prefix":"10.1096","volume":"13","author":[{"given":"RENHAI","family":"CAO","sequence":"first","affiliation":[{"name":"Laboratory of Angiogenesis Research Microbiology and Tumor Biology Center Karolinska Institute S\u2010171 77 Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JACOB","family":"FARNEBO","sequence":"additional","affiliation":[{"name":"Laboratory of Angiogenesis Research Microbiology and Tumor Biology Center Karolinska Institute S\u2010171 77 Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASASHI","family":"KURIMOTO","sequence":"additional","affiliation":[{"name":"Fujisaki Institute Hayashibara Biochemical Laboratories Inc. Okayama 702 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YIHAI","family":"CAO","sequence":"additional","affiliation":[{"name":"Laboratory of Angiogenesis Research Microbiology and Tumor Biology Center Karolinska Institute S\u2010171 77 Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[1999,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80108-7"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/386671a0"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81810-3"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0697-510"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512283332608"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0195-27"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/37126"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/362841a0"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90007-8"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/367576a0","article-title":"Glioblastoma growth inhibited in vitro by a dominantnegative Flk\u20101 mutant","volume":"367","author":"Millauer B.","year":"1994","journal-title":"Nature (London)"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90033-U"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90200-3"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0696-689"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81848-6"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-72149-6_8"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199509000-00001"},{"key":"e_1_2_6_18_1","first-page":"1798","article-title":"Interleukin\u20108 as a macrophage\u2010derived mediator of angiogenesis","volume":"256","author":"Kock A. E.","year":"1992","journal-title":"Science (Wash. DC)"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00916100"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9334"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1688470"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.1.155"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.3.981"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.1.219"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.6.2069"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508313330913"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1084\/jem.188.6.1039","article-title":"Inhibition of angiogenesis by interleukin 4","volume":"188","author":"Tepper R. I.","year":"1998","journal-title":"J. Exp. Med."},{"key":"e_1_2_6_28_1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jnci\/87.8.581","article-title":"Inhibition of angiogenesis in vivo by interleukin\u201012","volume":"87","author":"Voest E. E.","year":"1995","journal-title":"Natl. Cancer Inst."},{"key":"e_1_2_6_29_1","first-page":"1798","article-title":"Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity","volume":"51","author":"Maione T. E.","year":"1991","journal-title":"CancerRes."},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.3.1057"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0197-35"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/378088a0"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1555"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.6.1005"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.10.5217"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.472760"},{"key":"e_1_2_6_37_1","first-page":"4230","article-title":"A strategy to discover circulating angiogenesis inhibitors generated by human tumors","volume":"55","author":"Chen C.","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_6_38_1","first-page":"1625","article-title":"A model of angiogenesis in the mouse cornea","volume":"37","author":"Kenyon B. M.","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119069"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.46.29461"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.36.22924"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1558"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1197-1203"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1996.0272"},{"key":"e_1_2_6_45_1","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.4049\/jimmunol.156.11.4274","article-title":"Cloning of the cDNA for human IFN\u2010gamma\u2010inducing factor, expression in Escherichia coli, and studies on the biological activities of the protein","volume":"156","author":"Ushio S.","year":"1996","journal-title":"J. Immuol."},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/386619a0"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5297.206"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1373520"},{"key":"e_1_2_6_49_1","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.4049\/jimmunol.159.5.2125","article-title":"A mechanism underlying synergy between IL\u201012 and IFN\u2010gamma\u2010inducing factor in enhanced production of IFN\u2010gamma","volume":"159","author":"Ahn H. J.","year":"1997","journal-title":"J. Immunol."},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90352-6"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197111182852108"},{"key":"e_1_2_6_52_1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1172\/JCI119167","article-title":"IFN\u20107, IGIF, and IDDM","volume":"99","author":"Sarvetnick N.","year":"1997","journal-title":"J. Clin. Ivest."}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.13.15.2195","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fasebj.13.15.2195","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.13.15.2195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T22:43:44Z","timestamp":1761691424000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fasebj.13.15.2195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":51,"journal-issue":{"issue":"15","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["10.1096\/fasebj.13.15.2195"],"URL":"https:\/\/doi.org\/10.1096\/fasebj.13.15.2195","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]},"assertion":[{"value":"1999-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}